Русский

Pharmaceutical Industry Information Portal

HomeTagsBavarian Nordic

All posts by tag

Bavarian Nordic

Bavarian_Nordic_logoBavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company is headquartered in Hellerup, Denmark, while a manufacturing facility is located in Kvistgård.

World Pharma News

Bavarian Nordic expects new orders for monkeypox vaccine due to strong interest

Techno -
Biotechnology company Bavarian Nordic (BAVA.CO) expects to sign more contracts for its vaccine against monkeypox after "overwhelming" interest from governments around the world, its...
World Pharma News

Bavarian Nordic signs contract to supply smallpox vaccine due to an increase in cases of monkeypox

Techno -
Bavarian Nordic A/S announced today the signing of a supply contract with an undisclosed country for the Company’s smallpox vaccine with the aim to...
Pharmaceutical Investing News

Bavarian Nordic starts share buy-back program

Techno -
Bavarian Nordic A/S May 9th announced the initiation of a new share buy-back program, under which the Company intends to buy back up to...
Discovery and Development

Bavarian Nordic opens potential Chinese market for RSV vaccine

Techno -
Bavarian Nordic announced, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-based specialty pharmaceutical company, on the...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories